Here Is Why Workiva (WK) Appears So Attractive

Workiva Incorporated (NYSE:WK) is 1 of the 12 oversold bundle stocks to put in.

As of the February 16 closing, sentiment astir Workiva Incorporated (NYSE:WK) remains highly bullish. The banal received Buy ratings from each 4 analysts covering it. It has a projected median 1-year terms people of $109, implying 76% upside.

RomarioIen/Shutterstock.com

On February 9, Terry Tillman of Truist Securities reaffirmed his Buy standing connected Workiva Incorporated (NYSE:WK). He acceptable a $110 terms people for the stock, implying astir 78% upside from the existent level.

Tillman noted comparatively amended show from Workiva Incorporated (NYSE:WK) compared with the median 21% driblet crossed the bundle names it tracks. He highlighted the company’s “unique quality of markets served with tech, competitory & web effect moats.”

Tillman besides shared optimism astir the company’s maturation prospects based connected subscription and enactment revenues. As per his forecast, the institution tin registry maturation successful the high-teens to supra 20%, implicit a prolonged horizon.

Workiva Incorporated (NYSE:WK) is simply a exertion institution that offers a cloud-based SaaS level for reporting solutions. The level enables an integrated, audit-ready reporting strategy for ESG, financial, and GRC data. Its capabilities see data-linking, audit trail, head entree management, information transformation, ERP solutions, and quality superior management.

While we admit the imaginable of WK arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 15 Most Promising Mid-Cap Healthcare Stocks Under $50 and 11 Most Promising Small-Cap Industrial Stocks Under $50.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.